Page 117 - OR-1-3

of Hif-1α in activation of γ-secretase and notch signaling in prostate cancer cells. Cancer Res. 2004;64(15):5311-5321.
breast cancer. Cell Rep. 2014;8(4):1077-1092.
doi: 10.1158/0008-5472.CAN-2506-2
doi: 10.1016/j.celrep.2014.07.028
52. Mao H, Zhao X, Sun S. NF-κB in inflammation and cancer.
41. Burger JA, Kipps TJ. CXCR4: A key receptor in the crosstalk Cell Mol Immunol. 2025;22:811-839.
between tumor cells and their microenvironment. Blood.
2006;107(5):1761-1767. doi: 10.1038/s41423-025-01310-w
53. Xie Y, Liu F, Wu Y, et al. Inflammation in cancer: Therapeutic
doi: 10.1182/blood-2005-08-3182
opportunities from new insights. Mol Cancer. 2025;24(1):51.
42. Engl T, Relja B, Marian D, et al. CXCR4 chemokine receptor
mediates prostate tumor cell adhesion through alpha5 and doi: 10.1186/s12943-025-02243-8
beta3 integrins. Neoplasia. 2006;8(4):290-301. 54. Haider M, Ridlmaier N, Smit DJ, Taipaleenmäki H.
doi: 10.1593/neo.05694 Interleukins as mediators of the tumor cell-bone cell crosstalk
during the initiation of breast cancer bone metastasis. Int J
43. Sun Y, Fang M, Wang J, Cooper CR, Pienta KJ, Mol Sci. 2021;22(6):2898.
Taichman RS. Expression and activation of alpha v beta 3
integrins by SDF-1/CXC12 increases the aggressiveness of doi: 10.3390/ijms22062898
prostate cancer cells. Prostate. 2007;67(1):61-73. 55. Edwards CM, Johnson RW. From good to bad: The opposing
doi: 10.1002/pros.20500 effects of PTHrP on tumor growth, dormancy, and metastasis
throughout cancer progression. Front Oncol. 2021;11:644303.
44. Chinni SR, Sivalogan S, Dong Z, et al. CXCL12/CXCR4
signaling activates Akt-1 and MMP-9 expression in prostate doi: 10.3389/fonc.2021.644303
cancer cells: The role of bone microenvironment-associated 56. Patras L, Paul D, Matei IR. Weaving the nest: Extracellular
CXCL12. Prostate. 2006;66(1):32-48. matrix roles in pre-metastatic niche formation. Front Oncol.
doi: 10.1002/pros.20318 2023;13:1163786.
45. Cabioglu N, Summy J, Miller C, et al. CXCL-12/stromal doi: 10.3389/fonc.2023.1163786
cell-derived factor-1alpha transactivates HER2-neu in 57. Bourboulia D, Stetler-Stevenson WG. Matrix
breast cancer cells by a novel pathway involving Src kinase metalloproteinases (MMPs) and tissue inhibitors of
activation. Cancer Res. 2005;65(15):6493-6497. metalloproteinases (TIMPs): Positive and negative regulators
doi: 10.1158/0008-5472.CAN-04-1303 in tumor cell adhesion. Semin Cancer Biol. 2010;20(3):
161-168.
46. Liu S, Xie SM, Liu W, et al. Targeting CXCR4 abrogates
resistance to trastuzumab by blocking cell cycle progression doi: 10.1016/j.semcancer.2010.05.002
and synergizes with docetaxel in breast cancer treatment. 58. Sieber S, Wirth L, Cavak N, et al. Bone marrow-on-a-chip:
Breast Cancer Res. 2023;25(1):62.
Long‐term culture of human haematopoietic stem cells in a
doi: 10.1186/s13058-023-01665-w three‐dimensional microfluidic environment. J Tissue Eng
47. Prunier C, Baker D, Ten Dijke P, Ritsma L. TGF-β family Regen Med. 2018;12(2):479-489.
signaling pathways in cellular dormancy. Trends Cancer. doi: 10.1002/term.2507
2019;5(1):66-78.
59. Kotha SS, Hayes BJ, Phong KT, et al. Engineering a
doi: 10.1016/j.trecan.2018.10.010 multicellular vascular niche to model hematopoietic cell
48. Drabsch Y, Ten Dijke P. TGF-β signalling and its role in trafficking. Stem Cell Res Ther. 2018;9(1):77.
cancer progression and metastasis. Cancer Metastasis Rev. doi: 10.1186/s13287-018-0808-2
2012;31(3-4):553-568.
60. Marturano-Kruik A, Nava MM, Yeager K, et al. Human
doi: 10.1007/s10555-012-9375-7 bone perivascular niche-on-a-chip for studying metastatic
49. Ghajar CM, Peinado H, Mori H, et al. The perivascular colonization. Proc Natl Acad Sci U S A. 2018;115(6):1256-1261.
niche regulates breast tumour dormancy. Nat Cell Biol. doi: 10.1073/pnas.1714282115
2013;15(7):807-817.
61. Hao S, Ha L, Cheng G, et al. A spontaneous 3D bone-on-a-
doi: 10.1038/ncb2767 chip for bone metastasis study of breast cancer cells. Small.
50. Lopes-Bastos B, Jin L, Ruge F, et al. Association of breast 2018;14(12):e1702787.
carcinoma growth with a non-canonical axis of IFNγ/IDO1/ doi: 10.1002/smll.201702787
TSP1. Oncotarget. 2017;8(49):85024-85039.
62. Aleman J, George SK, Herberg S, et al. Deconstructed
doi: 10.18632/oncotarget.18781 microfluidic bone marrow on-a-chip to study normal and
51. Aalinkeel R, Nair MPN, Sufrin G, et al. Gene expression of malignant hemopoietic cell-niche interactions. Small.
angiogenic factors correlates with metastatic potential of 2019;15(43):e1902971.

Volume 1 Issue 3 (2025) 20 doi: 10.36922/OR025200017